Anuh Pharma Limited (BOM:506260)

Anuh Pharma Statistics

Total Valuation

Anuh Pharma has a market cap or net worth of INR 7.29 billion. The enterprise value is 7.16 billion.

Market Cap	7.29B
Enterprise Value	7.16B

Important Dates

The next estimated earnings date is Saturday, February 14, 2026.

Earnings Date	Feb 14, 2026
Ex-Dividend Date	Aug 14, 2025

Share Statistics

Anuh Pharma has 100.22 million shares outstanding. The number of shares has decreased by -0.10% in one year.

Current Share Class	100.22M
Shares Outstanding	100.22M
Shares Change (YoY)	-0.10%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	71.84%
Owned by Institutions (%)	0.00%
Float	27.92M

Valuation Ratios

The trailing PE ratio is 18.82.

PE Ratio	18.82
Forward PE	n/a
PS Ratio	1.00
PB Ratio	2.23
P/TBV Ratio	2.23
P/FCF Ratio	n/a
P/OCF Ratio	59.81
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.28, with an EV/FCF ratio of -122.36.

EV / Earnings	18.50
EV / Sales	0.98
EV / EBITDA	12.28
EV / EBIT	14.89
EV / FCF	-122.36

Financial Position

The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.00.

Current Ratio	2.11
Quick Ratio	1.39
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	-0.04
Interest Coverage	80.07

Financial Efficiency

Return on equity (ROE) is 12.29% and return on invested capital (ROIC) is 12.54%.

Return on Equity (ROE)	12.29%
Return on Assets (ROA)	6.38%
Return on Invested Capital (ROIC)	12.54%
Return on Capital Employed (ROCE)	14.62%
Weighted Average Cost of Capital (WACC)	6.60%
Revenue Per Employee	24.75M
Profits Per Employee	1.31M
Employee Count	295
Asset Turnover	1.55
Inventory Turnover	6.06

Taxes

In the past 12 months, Anuh Pharma has paid 127.05 million in taxes.

Income Tax	127.05M
Effective Tax Rate	24.71%

Stock Price Statistics

The stock price has decreased by -28.05% in the last 52 weeks. The beta is 0.42, so Anuh Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-28.05%
50-Day Moving Average	78.42
200-Day Moving Average	89.24
Relative Strength Index (RSI)	35.13
Average Volume (20 Days)	4,600

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Anuh Pharma had revenue of INR 7.30 billion and earned 387.14 million in profits. Earnings per share was 3.87.

Revenue	7.30B
Gross Profit	1.57B
Operating Income	480.99M
Pretax Income	514.19M
Net Income	387.14M
EBITDA	578.96M
EBIT	480.99M
Earnings Per Share (EPS)	3.87

Balance Sheet

The company has 130.96 million in cash and 2.27 million in debt, with a net cash position of 128.69 million or 1.28 per share.

Cash & Cash Equivalents	130.96M
Total Debt	2.27M
Net Cash	128.69M
Net Cash Per Share	1.28
Equity (Book Value)	3.27B
Book Value Per Share	32.64
Working Capital	1.99B

Cash Flow

In the last 12 months, operating cash flow was 121.88 million and capital expenditures -180.40 million, giving a free cash flow of -58.52 million.

Operating Cash Flow	121.88M
Capital Expenditures	-180.40M
Free Cash Flow	-58.52M
FCF Per Share	-0.58

Margins

Gross margin is 21.45%, with operating and profit margins of 6.59% and 5.30%.

Gross Margin	21.45%
Operating Margin	6.59%
Pretax Margin	7.04%
Profit Margin	5.30%
EBITDA Margin	7.93%
EBIT Margin	6.59%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 1.03%.

Dividend Per Share	0.75
Dividend Yield	1.03%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	5
Payout Ratio	38.78%
Buyback Yield	0.10%
Shareholder Yield	1.15%
Earnings Yield	5.31%
FCF Yield	-0.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 15, 2025. It was a forward split with a ratio of 2.

Last Split Date	Jul 15, 2025
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	4